Yesterday | Richmond Times-Dispatch
Intelliject gets financing for product development
Intelliject Inc., a Richmond-based company that developed a device for treatment of severe allergic reactions, said Tuesday it has received a $15 million loan to help it create a pipeline of new products.
Pfizer, Sanofi agree to settle EpiPen suit
Pfizer and Mylan say they have agreed to settle their patent infringement lawsuit against the French drugmaker Sanofi over pre-filled injections designed to treat severe allergic reactions.
Flint Township/Swartz Creek Advance
Pfizer reaches settlement with EpiPen rival
Pfizer and one of its subsidiaries reached a settlement with Intelliject and Sanofi-Aventis to allow a rival to the EpiPen auto-injector, called e-cue, to be launched in November 2012, Pfizer announced today.
Antares Progress Refires Bullish Call
A patent published last week signals that Antares is one step closer to announcing its first "QS" project.